Levothyroxine Sod 100mcg Inj, 1vial

Manufacturer FRESENIUS KABI Active Ingredient Levothyroxine Injection Solution(lee voe thye ROKS een) Pronunciation lee voe thye ROKS een
WARNING: Do not use this drug for weight loss. Severe and sometimes deadly side effects may happen with this drug if it is taken in large doses or with other drugs for weight loss. If you have questions, talk with the doctor. @ COMMON USES: It is used to add thyroid hormone to the body.It is used to manage thyroid cancer.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Thyroid hormone replacement
đŸ§Ŧ
Pharmacologic Class
Thyroid hormones
🤰
Pregnancy Category
Category A
✅
FDA Approved
Jan 1955
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Levothyroxine is a man-made form of a hormone normally produced by your thyroid gland. It's used to replace missing thyroid hormone in people whose thyroid gland doesn't produce enough (hypothyroidism). The injection form is typically used when you can't take the medicine by mouth, such as during severe illness or surgery, or in emergency situations like myxedema coma.
📋

How to Use This Medicine

To use this medication correctly, follow your doctor's instructions and carefully read all accompanying information. Take this medication exactly as directed, and be sure to follow all instructions provided. This drug is administered via intravenous injection.

If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage method.

In the event that you miss a dose, contact your doctor immediately to receive guidance on the appropriate course of action.
💡

Lifestyle & Tips

  • Maintain a consistent diet; certain foods (e.g., soy, high-fiber) can affect absorption of oral levothyroxine, though less relevant for IV.
  • Report any new or worsening symptoms to your doctor.
  • Do not stop taking this medication without consulting your doctor.
  • Regular follow-up appointments and blood tests are crucial to ensure the correct dose.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Highly individualized based on patient's TSH levels, clinical response, and specific indication (e.g., hypothyroidism, myxedema coma). For hypothyroidism, initial IV dose is typically 50% of the calculated oral maintenance dose. For myxedema coma, a loading dose of 300-500 mcg IV is common, followed by daily maintenance.

Condition-Specific Dosing:

hypothyroidism_initial_IV: Typically 50% of the calculated oral maintenance dose. For patients unable to take oral, the IV dose is approximately 50% of the oral dose.
myxedema_coma_loading: 300-500 mcg IV as a single dose. Some protocols suggest 200-500 mcg IV, followed by daily maintenance.
myxedema_coma_maintenance: 75-100 mcg IV daily, adjusted based on clinical response and thyroid function tests.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established for routine IV use; oral is preferred. For severe congenital hypothyroidism or myxedema coma, IV dosing may be considered, but specific guidelines are limited and highly individualized (e.g., 10-15 mcg/kg/day IV initially, then adjusted).
Infant: Not established for routine IV use; oral is preferred. If IV is necessary, highly individualized.
Child: Not established for routine IV use; oral is preferred. If IV is necessary, highly individualized.
Adolescent: Not established for routine IV use; oral is preferred. If IV is necessary, highly individualized, often similar to adult dosing but adjusted for weight and TSH.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment required.
Moderate: No specific dose adjustment required.
Severe: No specific dose adjustment required.
Dialysis: No specific dose adjustment required. Levothyroxine is highly protein-bound and not significantly removed by dialysis.

Hepatic Impairment:

Mild: No specific dose adjustment required.
Moderate: No specific dose adjustment required.
Severe: No specific dose adjustment required. However, severe hepatic impairment may alter protein binding and metabolism, requiring careful monitoring of thyroid function tests and clinical response.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Levothyroxine sodium is a synthetic L-isomer of thyroxine (T4). T4 is converted to its active metabolite, L-triiodothyronine (T3), in peripheral tissues. T3 and T4 bind to thyroid receptor proteins in the cell nucleus and exert metabolic effects through gene transcription and protein synthesis, regulating metabolism, growth, and development.
📊

Pharmacokinetics

Absorption:

Bioavailability: IV administration provides 100% bioavailability, bypassing gastrointestinal absorption variability.
Tmax: Not applicable for IV administration (peak concentration is immediate).
FoodEffect: Not applicable for IV administration.

Distribution:

Vd: Approximately 10-13 L (for T4).
ProteinBinding: >99% (primarily to thyroxine-binding globulin (TBG), thyroxine-binding prealbumin (TBPA), and albumin).
CnssPenetration: Limited (T4 crosses the blood-brain barrier to a limited extent, but T3 is more readily transported).

Elimination:

HalfLife: Approximately 6-7 days (euthyroid individuals); 9-10 days (hypothyroid); 3-4 days (hyperthyroid).
Clearance: Approximately 0.05 L/hr (euthyroid).
ExcretionRoute: Primarily renal (approximately 80% of conjugated T4 and T3 metabolites), with some fecal excretion (approximately 20%).
Unchanged: Less than 1% of T4 is excreted unchanged.
âąī¸

Pharmacodynamics

OnsetOfAction: IV administration provides a more rapid onset of action compared to oral, with metabolic effects beginning within hours, but full therapeutic effect may take days due to the long half-life and need for T4 to T3 conversion.
PeakEffect: Clinical effects are gradual, with peak therapeutic effect often observed days to weeks after initiation or dose adjustment, reflecting the long half-life and accumulation to steady state.
DurationOfAction: Due to its long half-life, effects persist for several days after discontinuation.

Safety & Warnings

âš ī¸

Side Effects

Serious Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood pressure, including:
+ Severe headache or dizziness
+ Passing out
+ Changes in eyesight
Chest pain or pressure
Fast or abnormal heartbeat
Shortness of breath
Sudden weight gain or swelling in the arms or legs
Headache
Feeling tired or weak
Changes in appetite
Unintentional weight change
Diarrhea, stomach cramps, or vomiting
Mood changes, such as feeling irritable, nervous, excitable, anxious, or restless
Shakiness
Trouble sleeping
Sensitivity to heat
Excessive sweating
Fever
Muscle cramps
Muscle weakness
Flushing
Bone pain
Changes in menstrual periods
In children: hip or knee pain, or a limp
In infants: changes in the shape of the head and face

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people may not experience any side effects or may only have mild ones. If you are bothered by any of the following side effects or if they do not go away, contact your doctor:

* Hair loss (usually temporary and resolves on its own within the first few months of treatment)

Reporting Side Effects

This is not a complete list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Symptoms of too much thyroid hormone (hyperthyroidism): rapid heart rate, palpitations, chest pain, shortness of breath, excessive sweating, heat intolerance, nervousness, tremor, insomnia, diarrhea, unexplained weight loss.
  • Symptoms of too little thyroid hormone (hypothyroidism): extreme fatigue, cold intolerance, constipation, dry skin, hair loss, unexplained weight gain, depression, slow heart rate.
  • Signs of allergic reaction: rash, itching/swelling (especially of face/tongue/throat), severe dizziness, trouble breathing.
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction and its symptoms.
Certain health conditions, including:
+ Overactive thyroid gland (hyperthyroidism)
+ Weak adrenal gland (adrenal insufficiency)

This list is not exhaustive, and it is crucial to discuss all your health problems and medications with your doctor.

To ensure safe treatment, provide your doctor and pharmacist with a comprehensive list of:
All prescription and over-the-counter (OTC) medications you are taking
Natural products and vitamins you are using
* Any health problems you have

Do not start, stop, or change the dosage of any medication without first consulting your doctor to confirm it is safe to do so.
âš ī¸

Precautions & Cautions

Important Information for Patients Taking This Medication

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. To ensure uninterrupted treatment, do not allow your supply of this medication to run out. You may not experience the full effects of this medication for several weeks.

If you have diabetes (high blood sugar), consult your doctor, as this medication may affect your blood sugar control. Your doctor may need to adjust your diabetes medications. Monitor your blood sugar levels as directed by your doctor and undergo regular blood tests as advised.

If you are taking biotin or a product containing biotin, stop taking it at least 2 days before having your thyroid levels checked to ensure accurate test results.

High doses of this medication may increase the risk of osteoporosis (weak bones), particularly after menopause. Discuss your risk factors with your doctor, who can help determine if you are at higher risk of developing osteoporosis.

This medication may affect fertility, making it more difficult to become pregnant or father a child. If you plan to conceive, consult your doctor before starting treatment.

If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.

Pregnancy and Breastfeeding

Inform your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. Your doctor will discuss the potential benefits and risks of this medication to you and your baby.

Special Considerations for Children

If your child is taking this medication and experiences a change in weight, consult your doctor, as the dosage may need to be adjusted. Never give your child more of this medication than prescribed, as this can increase the risk of severe side effects.

In some cases, this medication may affect growth in children and teenagers. Regular growth checks may be necessary. Consult your doctor to discuss any concerns.
🆘

Overdose Information

Overdose Symptoms:

  • Headache
  • Irritability
  • Nervousness
  • Sweating
  • Diarrhea
  • Tachycardia (rapid heart rate)
  • Arrhythmias (irregular heart rhythm)
  • Angina pectoris (chest pain)
  • Tremor
  • Insomnia
  • Fever
  • Heat intolerance
  • Weight loss
  • In severe cases: heart failure, shock, coma, death.

What to Do:

Seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Management is supportive and symptomatic, including beta-blockers for cardiac effects, and measures to reduce absorption if oral overdose (not applicable for IV).

Drug Interactions

🔴

Major Interactions

  • Amiodarone (can cause hypo- or hyperthyroidism, alters T4 to T3 conversion)
  • Anticoagulants (e.g., Warfarin - may increase anticoagulant effect)
  • Beta-blockers (e.g., Propranolol - may decrease T3 conversion)
  • Cardiac glycosides (e.g., Digoxin - may decrease digoxin levels)
  • Sympathomimetics (e.g., Epinephrine - increased risk of cardiac adverse effects)
  • Tyrosine kinase inhibitors (e.g., Sunitinib, Imatinib - may increase levothyroxine requirements)
🟡

Moderate Interactions

  • Antacids (e.g., Aluminum hydroxide, Calcium carbonate - may impair absorption of oral levothyroxine, less relevant for IV but important if transitioning)
  • Iron supplements (may impair absorption of oral levothyroxine, less relevant for IV)
  • Sucralfate (may impair absorption of oral levothyroxine, less relevant for IV)
  • Bile acid sequestrants (e.g., Cholestyramine, Colestipol - may impair absorption of oral levothyroxine, less relevant for IV)
  • Proton pump inhibitors (e.g., Omeprazole - may impair absorption of oral levothyroxine, less relevant for IV)
  • Estrogens (e.g., Oral contraceptives, HRT - increase TBG, increasing levothyroxine requirements)
  • Androgens (decrease TBG, decreasing levothyroxine requirements)
  • Glucocorticoids (e.g., Dexamethasone - may decrease TSH secretion, alter T4 to T3 conversion)
  • Phenytoin, Carbamazepine, Rifampin (induce hepatic metabolism, increasing levothyroxine requirements)
  • Sertraline (may increase levothyroxine requirements)
  • Orlistat (may impair absorption of oral levothyroxine, less relevant for IV)
đŸŸĸ

Minor Interactions

  • Dietary fiber (may impair absorption of oral levothyroxine, less relevant for IV)

Monitoring

đŸ”Ŧ

Baseline Monitoring

Thyroid Stimulating Hormone (TSH)

Rationale: Primary indicator of thyroid function and adequacy of thyroid hormone replacement.

Timing: Prior to initiation of therapy.

Free Thyroxine (Free T4)

Rationale: Measures unbound, active T4. Useful in conjunction with TSH, especially in central hypothyroidism or when TSH is unreliable.

Timing: Prior to initiation of therapy.

Clinical signs and symptoms of hypothyroidism

Rationale: To establish baseline and monitor therapeutic response.

Timing: Prior to initiation of therapy.

Cardiac status (ECG, history of cardiovascular disease)

Rationale: Thyroid hormones increase cardiac workload; caution in patients with pre-existing heart conditions.

Timing: Prior to initiation, especially in elderly or those with cardiac risk factors.

Adrenal function (if adrenal insufficiency is suspected)

Rationale: Initiating thyroid hormone in undiagnosed adrenal insufficiency can precipitate adrenal crisis.

Timing: Prior to initiation if clinical suspicion exists.

📊

Routine Monitoring

Thyroid Stimulating Hormone (TSH)

Frequency: Every 4-6 weeks after initiation or dose change until stable, then every 6-12 months.

Target: 0.4-4.0 mIU/L (general target for primary hypothyroidism, individualized for specific conditions/patients).

Action Threshold: Adjust dose if TSH is outside target range; consider clinical picture.

Free Thyroxine (Free T4)

Frequency: Often monitored with TSH, especially if TSH is suppressed or in central hypothyroidism.

Target: 0.8-1.8 ng/dL (general target, individualized).

Action Threshold: Adjust dose if Free T4 is outside target range or inconsistent with TSH.

Clinical signs and symptoms (e.g., energy levels, weight, constipation, cold intolerance, skin/hair changes)

Frequency: At each clinical visit.

Target: Resolution or improvement of hypothyroid symptoms.

Action Threshold: Persistent or worsening symptoms may indicate need for dose adjustment or investigation of other causes.

Cardiac status (heart rate, rhythm, blood pressure)

Frequency: Regularly, especially during dose titration in patients with cardiovascular disease.

Target: Within normal limits or patient's baseline.

Action Threshold: Development of angina, arrhythmias, or other cardiac symptoms may require dose reduction or discontinuation.

đŸ‘ī¸

Symptom Monitoring

  • Fatigue
  • Weight changes (gain or difficulty losing)
  • Cold intolerance
  • Constipation
  • Dry skin
  • Hair loss
  • Bradycardia
  • Depression
  • Memory impairment
  • Muscle aches and weakness
  • Hoarseness
  • Puffiness in face/eyes
  • Menstrual irregularities (in women)
  • Nervousness
  • Palpitations
  • Tremor
  • Heat intolerance
  • Diarrhea
  • Weight loss (unintended)
  • Insomnia

Special Patient Groups

🤰

Pregnancy

Levothyroxine is Category A. Thyroid hormone requirements often increase during pregnancy. It is crucial to continue levothyroxine therapy and monitor TSH levels frequently (e.g., every 4-6 weeks) to ensure adequate thyroid hormone replacement for both maternal and fetal health. Untreated maternal hypothyroidism can lead to adverse pregnancy outcomes.

Trimester-Specific Risks:

First Trimester: Increased levothyroxine dose often needed due to increased TBG and fetal thyroid hormone demand. Untreated hypothyroidism in early pregnancy is associated with impaired neurocognitive development in the fetus.
Second Trimester: Continued monitoring and dose adjustment as needed.
Third Trimester: Continued monitoring and dose adjustment as needed. Dose may need to be increased further.
🤱

Lactation

Levothyroxine is compatible with breastfeeding (L1 - Safest). Minimal amounts are excreted into breast milk, and it does not adversely affect the nursing infant. It is essential for the mother's health and does not pose a risk to the infant.

Infant Risk: Low risk. No adverse effects reported in breastfed infants.
đŸ‘ļ

Pediatric Use

Dosing is highly individualized based on age, weight, and TSH levels. Oral administration is preferred for chronic therapy. IV levothyroxine is reserved for severe cases (e.g., myxedema coma) or when oral administration is not possible. Careful monitoring of growth, development, and thyroid function is essential.

👴

Geriatric Use

Elderly patients may be more sensitive to the effects of levothyroxine, particularly cardiovascular effects. Lower initial doses and slower titration are recommended. Close monitoring for cardiac symptoms is crucial.

Clinical Information

💎

Clinical Pearls

  • Levothyroxine IV is primarily used for patients unable to take oral medication or in emergency situations like myxedema coma.
  • The IV dose is typically 50% of the patient's usual oral maintenance dose due to 100% bioavailability.
  • For myxedema coma, a large loading dose is often given, followed by daily maintenance.
  • Always assess for adrenal insufficiency before initiating thyroid hormone replacement, especially in myxedema coma, to avoid precipitating an adrenal crisis.
  • Monitor TSH and Free T4 levels closely, as well as clinical symptoms, to guide dose adjustments.
  • Be cautious when administering to patients with pre-existing cardiovascular disease; start low and titrate slowly.
  • Many drugs can interact with levothyroxine, affecting its absorption, metabolism, or protein binding. Review concomitant medications carefully.
🔄

Alternative Therapies

  • Liothyronine (T3) injection (e.g., Triostat) - used in specific situations, often in combination with levothyroxine for myxedema coma, due to its faster onset and shorter half-life.
  • Oral levothyroxine (e.g., Synthroid, Levoxyl, Unithroid) - the standard long-term treatment for hypothyroidism.
💰

Cost & Coverage

Average Cost: Varies widely by manufacturer and pharmacy. For 100mcg vial, typically $20-$100+ per vial. per 1 vial
Generic Available: Yes
Insurance Coverage: Tier 1 or 2 (generic), Tier 3 (brand if available and preferred). Coverage depends on insurance plan formulary.
📚

General Drug Facts

If your symptoms or health problems persist or worsen, it is essential to contact your doctor for further guidance. To ensure safe use, never share your medication with others, and do not take medication prescribed for someone else. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly; do not flush them down the toilet or pour them down the drain unless instructed to do so by a healthcare professional. If you are unsure about the proper disposal method, consult your pharmacist, who can also inform you about potential drug take-back programs in your area. Some medications may come with an additional patient information leaflet, which your pharmacist can provide. If you have any questions or concerns about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. Be prepared to provide information about the medication taken, the amount, and the time it was taken to ensure prompt and effective treatment.